THIS IS THE IOM3 ARCHIVE SITE. The content on this page may be out of date.
Our new website with up to date information can be found at www.iom3.org
Biomedical Applications Division contacts
Board Members: |
|
|
Prof Andrew Lewis PhD CSi CChem FRSC FIMMM (Chair)
|
Director of Rearch & Development, Innovation Tel. +44 (0)1276 902204
|
|
Andy is the Director of Research & Development in the Innovation function of Biocompatibles UK Ltd (for more information on the company click here). He specialises in the development of advanced biomedical polymer systems, for instance, to enhance the biocompatibility of implants or to modulate delivery of active agents in the body. These technologies have been applied to novel drug-device combination products for use in interventional therapies in the treatment of cardiovascular disease and cancer. To date, he has generated over to 200 scientific publications and articles (H-index 46), 11 book chapters and 50 patent families/applications in the fields of polymers, biomaterials and drug delivery (28 of which are granted US patents). Andy is visiting Professor of Biomaterials & Drug Delivery at the University of Brighton where he lectures on Drug-Device Combination Products. In 2015 Andy was awarded the Chapman Medal for distinguished research in the field of biomedical materials, particularly with respect to biomaterials innovation, which has produced benefits for patients and/or contributed to associated opportunities for industry.
|
|
|
Dr Gabriela Juarez Martinez (Secretary)
|
KTN Ltd |
|
|
Professor of Materials Science |
|
Professor Best co-directs the Cambridge Centre for Medical Materials (CCMM), within the Department of Materials Science and Metallurgy (MSM), University of Cambridge. She has an international reputation for research in ceramics particularly in the field of bioactive ceramics and ceramic composites for skeletal repair. She has published over 130 papers and been invited to write chapters and edit books. She is Editor of Journal of Materials Science: Materials in Medicine. She has been awarded two prizes by the Institute of Materials Minerals and Mining, the Chapman Medal and the Kroll Medal. For more information see www.msm.cam.ac.uk/ccmm.
|
|
|
|
KTN Ltd |
|
Sue Dunkerton is Director at the Knowledge Transfer Network (KTN), responsible for priority themes within Health, Agri-Food and Bioscience & Biotechnology as well as H2020 and Smart Specialisation. From 2002 – 2014, Sue ran the Health KTN, and has prior experience in medical technologies, digital health, assisted living, regenerative medicine and stratified medicine. But her career started in materials, with a degree in Metallurgy from the University of Manchester (UMIST as was) and she moved into welding and joining technologies in her early life at TWI. Whilst at TWI, Sue built up an advanced materials and processing group encompassing polymers, ceramics, composites and electronics packaging. Her experience spanned various sectors with considerable time spent in aerospace and in later years in the medical sector.
|
|
|
|
|
|
David graduated with a degree in physics from the University of Bristol in 1986 joining Smith & Nephew (S&N) as a materials scientist in the same year. David initially worked as a scientist, and later a project leader, on a number of materials-related projects including wound dressings, adhesives, surgeons’ gloves, orthopaedic bearing materials and bone cements. In 1996 David was appointed Head of Materials Science, managing a department engaged in biomaterials and medical device testing and characterisation. In 2001, David joined the Enabling Technologies group at S&N as Technology Manager for Biomaterials, leading a research team that was active in developing technologies in areas such as high strength bioresorbable polymers, osteoconductive materials, bone cements, bone adhesives and shape memory polymers for medical applications. This was followed in 2010 with a position as Science Manager for Biomaterials, in which role he provided scientific expertise, and ensured scientific excellence, in biomaterials across S&N’s internal development programmes, technology evaluations and due diligence. In 2016 David joined Xiros Ltd as Head of New Technologies. In this role he is responsible for a Biomaterials Lab developing new fibres and materials and also for diversification of the Xiros product portfolio by identifying opportunities in new medical specialities and technologies that utilise the company’s core strengths in textiles, implants, biomedical fibres and manufacturing. Between 2006 and 2012 David held the role of Visiting Professor in Advanced Biomaterials at the University of Manchester. He is a Fellow of the IOM3. |
|
|
Dr Brian E Kent BSc CChem FRSC
|
|
|
Brian Kent trained as an analytical chemist, and spent his career at the former Laboratory of the Government Chemist (now privatised as LGC) and at the DTI. He was a member of the research team which developed glass ionomer cements, now widely used in dentistry, and later became Head of the Laboratory`s Materials Technology Group. During 1990-1999 he was Manager of the LINK Medical Implants Programme. It was during this period that he initiated The Biomaterials Partnership at LGC, and also approached the DTI to begin discussions which led to the establishment of that Department's Building up Biomaterials Programme. Now semi-retired, he undertakes occasional activities in connection both with the Medical Devices Faraday Partnership and the former DTI.
|
|
|
|
IRC in Biomedical Materials |
|
Professor P Vadgama is currently Director of the IRC in Biomedical Materials, Queen Mary, University of London and Professor of Clinical Biochemistry, Queen Mary's School of Medicine & Dentistry. Head of Service in the Department of Clinical Biochemistry, Barts and the Royal London NHS Trust.
|
|
|
Professor John Nicholson
|
School of Sports, Health and Applied Science, St Mary's University College, Waldegrave Road, Twickenham, Middlesex, TW1 4SX, United Kingdom |
|
Professor John Nicholson combines the role of Director of his own company, the Bluefield Centre for Biomaterials, London, with that of honorary Senior Research Fellow at the Institute of Dentistry, Queen Mary University of London. His research interests lie in the field of biomedical cements mainly for dental, and involves well-established collaborations with a variety of universities in the UK and abroad. A former President of the UK Society for Biomaterials, John has published almost 200 papers, and five books, the most recent being "Materials for the direct restoration of teeth" (Woodhead, 2016). |
|
|
|
LGC |
|
Julian Braybrook is Head of Measurement R&D within the Research and Technology Division of LGC, the UK's designated National Metrology Institute for chemical and bio-analytical measurement. A chemist by training, his role now lies predominantly in research innovation and management, underpinning the development and translation of some of the most challenging measurements of importance to the UK's industrial competitiveness and quality of life. This covers (bio-)pharmaceutical, diagnostic, security and healthcare technologies, and particularly the area of regenerative medicine, incorporating the more traditional biomaterials applications and the emerging tissue engineering and cell-based therapy applications. He has published numerous scientific publications and edited a book. He is a member of several British, European and international Standards Committees in the area of biological evaluation of medical devices, and a member of the Royal Society of Chemistry Biomaterials Committee. Until recently he was senior technical and financial adviser for biomaterial/medical device projects funded under the EU Framework Programmes. He is a Chartered Chemist and Fellow of the Royal Society of Chemistry.
|
|
|
Dr Julian Jones DIC MEng (Oxon) FIMMM |
Senior Lecturer |
|
Dr. Julian Jones is a Senior Lecturer at Imperial College London. His work focuses on the development, characterization (including 3D imaging and image analysis) of novel bioactive tissue scaffolds and their cellular response. His group have developed novel bioactive glasses and inorganic/ organic hybrid scaffolds with tailorable properties. His achievements have been recognized by the Tissue and Cell Engineering Society (TCES) Early Investigator award (2008), a prestigious 2007 Phillip Leverhulme Prize, a Royal Academy of Engineering/EPSRC Research Fellowship (2004) and the Institute of Materials, Mining and Minerals Silver Medal (2004) for outstanding achievement in the field of materials science. He is also Chair of Technical Committee 4 (TC04, Biomedical Glasses) of the International Commision for Glass (ICG), which aims to promote the use and advancement of glass technology internationally. |
|
|
|
University of Brighton, Pharmacy and Biomolecular Sciences Tel. +44 (0)1273 642083 |
|
Profesor Matteo Santin has achieved a Honour Degree in Biological Sciences, University of Naples, Italy, a PhD in Biomaterials, University of Naples, Italy, and a PhD in Biomedical Sciences, University of Brighton, UK. He is currently Reader in Tissue Regeneration at the School of Pharmacy and Biomolecular Sciences, University of Brighton, UK where he leads the Brighton Advanced Tissue and Organ Regeneration group. Dr Santin has been working in the field of biomaterials since 1991 and his research activity is mainly focussed onto the synthesis of biomimetic and bioactive biomaterials and onto developing clinically-reflective in vitro models testing host response to implants. In 2005, he received the Jean Leray Award by the European Society for Biomaterials. He is currently member of the European Society for Biomaterials Council and of the UK Society for Biomaterials Council.
|
|
|
|
Orthopaedic Research Unit |
|
Neil Rushton is Professor of Orthopaedics in Cambridge and Director of the Orthopaedic Research Unit. He has had a long term interest in the reaction between patients and implanted materials and was probably the first to identify the contribution of polyethylene wear particles to the process of aseptic loosening of prostheses. His work on the reaction of "bone cells" and materials is the mainstay of his work and involves many successful collaborative cross-disciplinary projects. He has been involved in "translational" research for more than 25 years. His current research includes the use of modern composite materials to match the modulus of the bone that it replaces; a concept that has led to the development of a new hip replacement system marketed by Stryker. The synthesis and subtle modification of bone and cartilage substitute materials has contributed to the commercialisation of the products. He works on nano materials, surface modification of implants and the use of stem cells and growth factors to enhance the fixation of prostheses is ongoing. Prof. Rushton's clinical interests lie in arthroplasty of the hip and knee joint arthroplasty. He was involved in the diagnosis and management of infected and loose hip replacement components and the development of revision arthroplasty. He is an Honorary Consultant Orthopaedic Surgeon, a Fellow of Magdalene College, a Fellow of the Royal College of Surgeons and a Fellow of the Institute of Materials, Minerals and Mining. He is also Emeritus Research Editor of the Journal of Bone and Joint Surgery and Past President of the European Orthopaedic Research Society.
|
|
|
|
Senior Lecturer, University College London |
|
Dr Jie Huang received a BSc Honours degree in Materials Science and Engineering in 1989 from East China University of Science and Technology at Shanghai, China and a PhD in Biomaterials in 1997 from Queen Mary, University of London.
|
|
|
|
Director of Research, School of Clinical Dentistry, The University of Sheffield, UK Professor of Biomaterials Science |
|
Paul has active research interests in biomaterials, medical devices and tissue engineering for clinical applications in human skeletal tissue repair and regeneration. The major themes for his research include the development of bioactive glasses and ceramics for mineralised tissue repair including their use in composites and at the nanoscale, the evaluation of safety and biocompatibility, and the development of scaffolds for musculoskeletal tissue engineering. He is also active more broadly in the promotion of academic-industrial collaboration and technology transfer in the orthopaedic, craniofacial and dental material sectors. He has an excellent research track record, a broad knowledge of current research, and strategic awareness based on over 25 years of experience in biomaterials research focussed primarily on the application of bioengineering to address clinical challenges. In this time, he has led a large number of research projects including European programmes valued well in excess of £10million, and he has been associated as a co-investigator in activities valued at over £25million. He has published over 80 full papers with many more reviews and book chapters, and currently has an h index of 28. Furthermore, he has supervised over 20 PhDs to successful completion. Currently, he leads Sheffield’s work within the EPSRC Centre for Innovative Manufacturing (MeDe Innovation) valued at approximately £6.5million, he is the Sheffield lead for an EPSRC “White Rose” Doctoral Training College in Tissue Engineering & Regenerative Medicine, and a co-investigator for the Polymer Centre EPSRC CDT. He has extensive experience of high-level work across the University and city as a former Co-Director of the Healthcare Gateway team and a member of Sheffield City Region LEP Healthtech Sector Group. He is a recipient of the UK Society for Biomaterials Alan Wilson Memorial Lecture Award and the Biocompatibles Endowed Prize, and a former member of the TERMIS-EU Council.
|
|
|
|
Department of Eye and Vision Science, University of Liverpool |
|
Rachel is a professor of ophthalmic bioengineering with over 20 years of experience in the design and development of advanced materials for medical applications. Her expertise lies particularly in the design and characterisation of the bulk and surface properties of materials and how to modify them to optimise the properties for a specific application. She currently leads the Ophthalmic Bioengineering theme at The University of Liverpool. She is leading research on strategies to develop innovative ways to modify materials and their surfaces to treat sight threatening conditions such as age-related macular degeneration (AMD), cataracts, retinal detachment and surface ocular disorders. She currently holds a Fellowship from the EPSRC on Building Advanced Materials to Treat Vision Loss under the Engineering Fellowships for Growth scheme. In 2014 she received a RISE (Recognising Inspirational Scientists and Engineers) award from the EPSRC.
|
|
|
|
Lucy Di Silvio Tel. +44 (0)207188 18 19 |
|
Lucy Di Silvio is Professor of Tissue Engineering, and Head of the Division of Tissue Engineering & Biophotonics at Guy’s, King’s and St. Thomas’ Schools (GKT) of Medicine & Dentistry, King’s College London, UK. The spectrum of activity within her group is based on tissue engineering through to clinical translation. The basic science focuses on the development of cell seeded constructs systems to restore function of traumatised or diseased hard and soft tissues for clinical maxillofacial, dental defects and other clinical applications. A key feature is the use of 3 dimensional co-culture systems for vascularization of scaffolds. The core research strategy of the group aims to consolidate the key elements for translating tissue engineered systems into clinical practice. She is immediate past Secretary of the European Society for Biomaterials and a Fellow of the Institute of Materials, Minerals and Mining. In 2020 she will be co-President of the 11th World Biomaterials Congress taking place in Glasgow.
|
|
| Dr Minoo Esat | Independent Industry Consultant |
